跳至主要内容
临床试验/NCT04203979
NCT04203979招募中不适用

Sepsis: From Syndrome to Personalized Care

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2020年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
1
主要终点
Area under the curve receiver operator characteristic (AUC - ROC) for inflammation biomarkers for detecting infection in critically ill patients.

研究概览

简要总结

This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.

详细描述

The study will prospectively include adult patients (>18 years) with suspected sepsis admitted to Oslo University Hospital, Ullevål (OUH-Ullevål). Patients admitted to the emergency department and managed by the medical rapid response team or the sepsis rapid response team are considered eligible for inclusion. Informed consent will be collected at the emergency department if possible, or within few days, by a clinical investigator or a study nurse. The investigators aim to include 1500 patients treated by the Sepsis Rapid Response Team or Medical Emergency team for possible sepsis. Patients classified to have had other conditions than sepsis in the post hoc assessment will be used as controls. The inclusion period will be 3 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • admitted to emergency department OUH, Ullevål.
  • managed by the medical rapid response team or the sepsis rapid response team

排除标准

  • Not given informed consent by patient or next of kin (if patient is not able to)

结局指标

主要结局

Area under the curve receiver operator characteristic (AUC - ROC) for inflammation biomarkers for detecting infection in critically ill patients.

时间窗: One year

Comparing area under the curve receiver operator characteristic (AUC - ROC) for calprotectin, pro-calcitonin, CRP and other biomarkers for detecting infections in critically ill patients in the Emergency department.

Number of sepsis patient with bacterial DNA detected in blood by molecular biological tests.

时间窗: One year

The performance of rapid molecular biological tests for detecting bacterial DNA in full blood in critically ill medical patients, compared to current state-of-the art diagnostics (blood culture).

Number of sepsis patient with elevated plasma-calprotectin

时间窗: One year

Sensitivity of plasma-calprotectin for detecting infections in critical ill medical patients in the Emergency department.

次要结局

  • Concentration of biomarkers in blood.(One year)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aleksander Rygh Holten

Principal Investigator

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验